GlassScriptPhysician profile
Emily Hart
NPI 1578153094
$1,240.77
in general payments reported to CMS, 2019-2025
20 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $231 · 2023: $213 · 2024: $250 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.44 | 2021-2025 | |
| Astellas Pharma US INC | $213.43 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $175.38 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $111.26 | 2021-2025 | |
| Biogen, INC. | $108.56 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $50.10 | 2021-2022 | |
| Daiichi Sankyo INC. | $48.01 | 2024-2025 | Injectafer |
| Organon LLC | $36.17 | 2023-2025 | Nexplanon |
| Aspira Women'S Health INC | $30.41 | 2022-2024 | Ova1 |
| Hologic Sales and Service, LLC | $28.72 | 2022-2024 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $27.35 | 2023 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $23.36 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $22.99 | 2024 | |
| Shield Therapeutics INC | $22.81 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $20.31 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $18.65 | 2025 | Intrarosa |
| Sumitomo Pharma America, INC. | $17.35 | 2023 | Myfembree |
| Coopersurgical, INC. | $16.44 | 2025 | Paragard T 380a |
| Pacira Pharmaceuticals Incorporated | $15.92 | 2021 | |
| Merck Sharp & Dohme LLC | $15.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.